Taiwan Reports First Human Case Of New Bird Flu Strain; Researchers Report Encouraging Results From H7N9 Vaccine Trial

“A woman in Taiwan has become the first person in the world with a confirmed case of a new strain of bird flu, adding to a growing body of evidence of the potential threat from animal viruses that mutate to be able to infect people,” Reuters reports (Kelland, 11/13). “The latest version is called H6N1, and represents the first time that this strain of bird flu has jumped from birds to people,” TIME notes (Park, 11/13). “The patient recovered and no other cases have been detected,” but “the Lancet Respiratory Medicine report said ‘intensive’ monitoring of bird flu was needed,” according to BBC News (Gallagher, 11/14).

“On a more hopeful front, two pharmaceuticals separately reported encouraging results from human tests of a possible vaccine against [H7N9,] a different type of bird flu that has been spreading in China since first being identified last spring, which is feared to have pandemic potential,” the Associated Press writes (Cheng, 11/14). “The encouraging results in the early stage trial from Novavax, a biopharmaceutical company based in Rockville, Maryland, were published online in the New England Journal of Medicine,” Reuters notes in a separate article, and describes the trial (Begley, 11/13).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KFF | twitter.com/kff

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.